CYP2C9 c.643-115A>G

Variant ID: 10-96708750-A-G

NM_000771.3(CYP2C9):c.643-115A>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs9332129
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.

Bmc Medical Genetics
Suriapranata, Ivet M IM; Tjong, Wen Ye WY; Wang, Tingliang T; Utama, Andi A; Raharjo, Sunu B SB; Yuniadi, Yoga Y; Tai, Susan Sw SS
Publication Date: 2011-06-06

Variant appearance in text: rs9332129
PubMed Link: 21639946
Variant Present in the following documents:
  • Main text
  • 1471-2350-12-80.pdf
View BVdb publication page



Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.

Human Genomics
Matimba, Alice A; Del-Favero, Jurgen J; Van Broeckhoven, Christine C; Masimirembwa, Collen C
Publication Date: 2009-01

Variant appearance in text: rs9332129
PubMed Link: 19164093
Variant Present in the following documents:
  • Main text
  • 1479-7364-3-2-169.pdf
View BVdb publication page